MMFP-Tableau offers a readily generalizable solution to make research and clinical electronic health system data more accessible and impactful.

Researchers at Children’s Hospital of Philadelphia (CHOP) announced the results of a new study highlighting significant genetic links in speech and language disorders in children.

CHOP researchers have developed a computational tool to determine which cells in patient tumor samples receive mitochondria from T cells.

CHOP researchers have developed a versatile and low-cost technology for targeted sequencing of full-length RNA molecules.

CHOP and UCLA researchers have created a tool that can discover tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets.

Findings demonstrate how a new computational method could effectively analyze phenotypes and identify similarities among patient populations.

CHOP researchers have developed a new computational tool that can more accurately discover and quantify RNA molecules from these error-prone long-read RNA sequencing data.

CHOP has helped launch NCI-backed “Molecular Targets Platform” to streamline and catalyze drug development by harmonizing data about pediatric cancer targets and pathways.

CHOP researchers have integrated environmental, genetic, and imaging data to better understand which factors might be clinically relevant when it comes to psychiatric and cognitive outcomes.

CHOP researchers have developed new software called CancerVar, which helps researchers assess the clinical impacts of over 13 million somatic cancer mutations.